Tirzepatide
Tirzepatide is an FDA-approved injectable medication that works as a dual GLP-1 and GIP receptor agonist. It is used primarily for type 2 diabetes and obesity/weight management.
$ 95.00 USD
Research Overview
Key Benefits
- Significant Weight Loss
- Clinical trials show 15–22% average body weight reduction over 72 weeks in people with obesity.
- Outperforms many other GLP-1–based therapies in weight-loss magnitude.
- Improved Blood Sugar Control
- Lowers HbA1c by up to 2% or more in type 2 diabetes.
- Enhances insulin sensitivity and reduces post-meal glucose spikes.
- Cardiometabolic Health
- Improves cholesterol and triglyceride levels.
- Modestly lowers blood pressure.
- May reduce long-term cardiovascular risk.
Important Notes
- Should be used under medical supervision, especially in patients with a history of pancreatitis or certain thyroid cancers.
Accepting
